PD-L1 on host cells is essential for PD-L1 blockade–mediated tumor regression
Author:
Funder
National institute of health
Publisher
American Society for Clinical Investigation
Subject
General Medicine
Link
https://www.jci.org/articles/view/96061/files/pdf
Reference35 articles.
1. PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
2. Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
3. Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
4. Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
Cited by 412 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Nanoreactors with Cascade Catalytic Activity Reprogram the Tumor Microenvironment for Enhanced Immunotherapy by Synchronously Regulating Treg and Macrophage Cells;ACS Applied Materials & Interfaces;2024-09-06
2. INHBA promotes tumor growth and induces resistance to PD-L1 blockade by suppressing IFN-γ signaling;Acta Pharmacologica Sinica;2024-09-02
3. Lymphatic system regulation of anti-cancer immunity and metastasis;Frontiers in Immunology;2024-08-15
4. Interferon-γ driven differentiation of monocytes into PD-L1+and MHC II+macrophages and the frequency of Tim-3+tumor-reactive CD8+T cells within the tumor microenvironment predict a positive response to anti-PD-1-based therapy in tumor-bearing mice;2024-08-04
5. The expression of immune checkpoint proteins PD‐L1 and TIM3 in mouse and human head and neck squamous cell carcinoma;European Journal of Oral Sciences;2024-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3